The 98thAnnual Meeting of the American Association for Thoracic Surgery (AATS) opened at the San Diego International Conference Center in California on April 28th. Thousands of experts and scholars from all over the world participated in this year’s meeting. Among them was Professor Liu Lunxu of SCU’s West China Hospital, who was newly elected to the AATS for his leading role in developing the “single-direction VATS lobectomy” and for his crucial contributions to thoracic surgery in China as one of the country’s first thoracic surgeons to perform VATS lobectomy comprehensively to treat lung cancer.
At this year’s meeting, five nominees from China were elected new members of the AATS, four experts from the field of thoracic surgery and one expert in cardiac surgery. They were Professor Chen Chang, Vice Dean of the Shanghai Pulmonary Hospital, Shanghai Jiao Tong University; Professor Jiang Gening, Chief of the Department of Thoracic Surgery of Shanghai Pulmonary Hospital, Shanghai Jiao Tong University; Professor Liu Lunxu, Vice President of West China Hospital & Vice Dean of West China School of Medicine of Sichuan University; Professor Tan Lijie, Deputy Director of Department of Thoracic Surgery, Chief of Department of Esophageal Diseases from Zhongshan Hospital, Fudan University; and Professor Wang Chunsheng, Chief of Department of Cardiology of Zhongshan Hospital, Fudan University.
Professor Liu Lunxu has played a leading role in China in the introduction of complete video-assisted thoracoscopic surgery (VATS) as a radical treatment for lung cancer. In the international arena, he developed the “single-direction VATS lobectomy” and was the first surgeon to treat central lung cancer by performing complete VATS bronchovascular double sleeve lobectomy. He developed the non-grasping en bloc mediastinal lymph node dissection (MLND), “suction-compressing angiorrhaphy technique (SCAT)” for thoracoscopic massive hemorrhage, and comprehensive treatment strategies for complex anatomy of hilum. Liu also performed the first successful bilateral lung transplantation in western China. He has won the Chinese Medical Sci-Tech Advance Award (first class) and the Sichuan Provincial Science and Technology Advance Award (first class). Liu’s election to the AATS not only recognizes Liu’s significant efforts and achievements in minimally invasive thoracic surgery, but also encourages continued contributions to the diagnosis and treatment of thoracic heart disease worldwide.
The American Association for Thoracic Surgery (AATS) is an international organization that encourages, promotes, and stimulates the scientific investigation of cardiothoracic surgery. Founded in 1917 by a respected group of the earliest pioneers in the field, its original mission was to “foster the evolution of an interest in surgery of the Thorax.” Today, the AATS is the premiere association for cardiothoracic surgeons in the world and works to continually enhance the ability of cardiothoracic surgeons to provide the highest quality of patient care. Its more than 1,400 members from 41 different countries have a proven record of distinction within the specialty and have made significant contributions to the care and treatment of cardiothoracic disease. AATS has strict requirements for membership application. Its members have a good reputation in the field of cardiothoracic surgery and have made active contributions to the diagnosis and treatment of cardiothoracic disease in the world. Elected members are not only leading scientists in their fields of specialization, but also front-line experts and project leaders in their respective disciplines.
Prof. Liu Lunxu is the Vice President of West China Hospital & Vice Dean of West China School of Medicine of Sichuan University, professor, chief physician, doctoral tutor, Fellow of The Royal College of Surgeons (RCS), member of the AATS, and winner of the distinguished title of “Young and Mid-career Expert with Outstanding Contributions to National Health and China’s Family Planning Commission.” Currently he also serves as Vice President of the Chinese Association of Thoracic Surgeons and the Chairman of Expert Committee of Minimally Invasive Thoracic Surgery of Chinese Association of Thoracic Surgeons, Standing Committee Member of the Chinese Society for Thoracic and Cardiovascular Surgery and Head of the Thoracoscopic Surgery Group of the Chinese Society for Thoracic and Cardiovascular Surgery, Committee member of the Chinese Anti-cancer Association (Lung Cancer), Vice Chairman of the Expert Committee of Thoracic Surgery of the Chinese Research Hospital Association, Vice Chairman of the Thoracic Surgery Group and Chief of ERAS Group of the China International Exchange and Promotion Association for Medical and Healthcare, and Vice Chairman of the Integrated Thoracic Surgery Committee of the Chinese Association of Integrated Medicine. He also sits on the editorial board of theChinese Journal of Clinical Thoracic and Cardiovascular Surgery andVideo-Assisted Thoracic Surgery.